Skip to content

An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease

An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00409279
Enrollment
100
Registered
2006-12-08
Start date
2003-09-30
Completion date
2008-04-30
Last updated
2008-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease

Keywords

Aging, Parent / Adult-child interaction, Family caregivers, Alzheimer's, Caregiving

Brief summary

The goal of this project is to test an intervention designed to reduce the incidence and magnitude of the negative effects, specifically stress, anxiety, and depression, frequently experienced by adult children who are caregivers of a parent with Alzheimer's disease (AD).

Detailed description

Caring for an elderly parent is a growing societal problem, and many studies have shown that caring for a person with dementia can have a negative impact on a caregiver's psychological and physical health, social life and career, and relationship with the patient. Stress and coping models proposed in the AD caregiving literature, and general stress and coping theories suggest that by improving caregivers' ability to cope and master the caregiving situation, it is possible to avoid or ameliorate the negative emotional consequences of caregiving. Building upon the results of a pilot study, this study will formally test the efficacy of a psychosocial intervention, based on a concept of caregiving that builds on the interests, activities, and responsibilities of both the caregiver and patient in creating a care strategy. The intervention is designed to reduce the negative effects frequently experienced by adult children who care for a parent in the middle stage of Alzheimer's disease. Caregivers will learn to engage with their parents in activities that are within the patients' remaining functional and cognitive abilities. Caregivers will also be encouraged to teach activities to other family members and paid caregivers. The study will also evaluate a lower level of intervention, based on written materials. It is expected that by increasing knowledge about AD and providing what may be a new conceptual approach to relating to a parent at this point in the disease process, 1) caregivers and patients may experience a higher level of satisfaction and gratification from their interactions, 2) caregivers will gain a sense of control and mastery over a difficult situation and thus feel more capable of coping and 3) the patient may maintain a higher level of functioning. A randomized treatment/control design will be used, and adult-child caregivers who participate will be assigned to one of the two levels of intervention, each designed to reduce stress, anxiety and depression. The benefits of each intervention will be evaluated by looking at the change in scores on widely used measures of the anticipated outcomes among caregivers in each group, and their relative benefits will be tested by comparing scores of the caregivers in the two groups at two follow-up points, six and nine months after baseline.

Interventions

individual-family consultation, support group, and ad hoc consultation

Sponsors

The Jacob and Valeria Langeloth Foundation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
21 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Men or women between the ages of 21 and 90 * Adult-child caring for at least one parent who has been diagnosed with Alzheimer's disease and is in the moderate stage * Person with Alzheimer's disease must be living at home or in a congregate residential setting that is like a home * Caregiver must be willing to complete intake and follow-up questionnaires * Caregiver must be willing to attend 2 workshops and 1 individual counseling session

Exclusion criteria

* Severe psychological or physical illness * Unwillingness to participate in all aspects of the study

Design outcomes

Primary

MeasureTime frame
Changes in measures of depression, stress, and anxietysix and nine months from baseline

Countries

United States

Contacts

Primary ContactOlanta Barton
olanta.barton@med.nyu.edu212-263-5710

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026